EFEMP1 expression promotes angiogenesis and accelerates the growth of cervical cancer in vivo

Gynecologic Oncology

Volumn 121, Issue 1, 2011, Pages 174-180

  Song, En Lin ^a,b   Hou, Ya Ping ^a   Yu, Shen Ping ^c   Chen, Sheng Guo ^a   Huang, Jun Ting ^a   Luo, Tao ^a   Kong, Ling Ping ^a   Xu, Jie ^a   Wang, Hua Qiao ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b NANCHANG UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

Angiogenesis; Cervical carcinoma; Epidermal growth factor containing; fibulin like extracellular matrix; protein 1 (EFEMP1); VEGF

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CD34 ANTIGEN; EFEMP1 PROTEIN; EPIDERMAL GROWTH FACTOR CONTAINING FIBULIN LIKE EXTRACELLULAR MATRIX PROTEIN 1; LIPOFECTAMINE; PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CELL ADHESION; CELL ASSAY; CELL INVASION; CELL LABELING; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC TRANSFECTION; GROWTH RATE; HELA CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL VEIN; UPREGULATION; UTERINE CERVIX CANCER; WESTERN BLOTTING;

ANIMALS; CELL GROWTH PROCESSES; CELL MOVEMENT; CELL SURVIVAL; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; RECOMBINANT PROTEINS; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; UTERINE CERVICAL NEOPLASMS;

EID: 79952814062     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.11.004     Document Type: Article

References (30)

1. Kodama J, Seki N, Masahiro S, Kusumoto T, Nakamura K, Hongo A, et al. Prognostic factors in stage IB-IIB cervical adenocarcinoma patients treated with radical hysterectomy and pelvic lymphadenectomy. J Surg Oncol 2010;101(5):413-7.
2. Phoophitphong T, Hanprasertpong J, Dechsukhum C, Geater A. Correlation of angiogenesis and recurrence-free survival of early stage cervical cancer patients undergoing radical hysterectomy with pelvic lymph node dissection. J Obstet Gynaecol Res 2007;33(6):840-8. (Pubitemid 350086518)
3. Ancuta C, Ancuţa E, Zugun-Eloae F, Carasevici E. Neoangiogenesis in cervical cancer: focus on CD34 assessment. Rom J Morphol Embryol 2010;51(2):289-94.
4. Formenti S, Felix J, Salonga D, Danenberg K, Pike MC, Danenberg P. Expression of metastases-associated genes in cervical cancers resected in the proliferative and secretory phases of the menstrual cycle. Clin Cancer Res 2000;6(12):4653-7. (Pubitemid 32110401)
5. Dellas A, Moch H, Schultheiss E, Feichter G, Almendral AC, Gudat F, et al. Angiogenesis in cervical neoplasia: microvessel quantitation in precancerous lesions and invasive carcinomas with clinicopathological correlations. Gynecol Oncol 1997;67(1):27-33. (Pubitemid 27433324)
6. Timpl R, Sasaki T, Kostka G, Chu ML. Fibulins: a versatile family of extracellular matrix proteins. Nat Rev Mol Cell Biol 2003;4(6):479-89. (Pubitemid 36648593)
7. Stone EM, Lotery AJ, Munier FL, Héon E, Piguet B, Guymer RH, et al. A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat Genet 1999;22(2):199-202. (Pubitemid 29264819)
8. Roybal CN, Marmorstein LY, Vander Jagt DL, Abcouwer SF. Aberrant accumulation of fibulin-3 in the endoplasmic reticulum leads to activation of the unfolded protein response and VEGF expression. Invest Ophthalmol Vis Sci 2005;46(11):3973-9. (Pubitemid 44264595)
9. Marmorstein LY, Munier FL, Arsenijevic Y, Schorderet DF, McLaughlin PJ, Chung D, et al. Aberrant accumulation of EFEMP1 underlies drusen formation in Malattia Leventinese and age-related macular degeneration. Proc Natl Acad Sci USA 2002;99(20):13067-72.
10. Albig AR, Neil JR, Schiemann WP. Fibulins 3 and 5 antagonize tumor angiogenesis in vivo. Cancer Res 2006;66(5):2621-9.
11. Sadr-Nabavi A, Ramser J, Volkmann J, Naehrig J, Wiesmann F, Betz B, et al. Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker. Int J Cancer 2009;124(7):1727-35.
12. Seeliger H, Camaj P, Ischenko I, Kleespies A, De Toni EN, Thieme SE, et al. EFEMP1 expression promotes in vivo tumor growth in human pancreatic adenocarcinoma. Mol Cancer Res 2009;7(2):189-98.
13. En-lin S, Sheng-guo C, Hua-qiao W. The expression of EFEMP1 in cervical carcinoma and its relationship with prognosis. Gynecol Oncol 2010;117(3):417-22.
14. Yao JF, Ji YF, Shi YF. Microvessel density, epithelial-stromal vascular cuffing and expression of vascular endothelial growth factor in human cervical carcinoma. Zhejiang Da Xue Xue Bao Yi Xue Ban 2003;32(1):62-6.
15. Shock A, Rabe KF, Dent G, Chambers RC, Gray AJ, Chung KF, et al. Eosinophils adhere to and stimulate replication of lung fibroblasts 'in vitro'. Clin Exp Immunol 1991;86(1):185-90.
16. Gao J, Sun L, Huo L, Liu M, Li D, Zhou J. CYLD regulates angiogenesis by mediating vascular endothelial cell migration. Blood 2010;115(20):4130-7.
17. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992;84(24):1875-87. (Pubitemid 23004615)
18. Schiemann WP, Blobe GC, Kalume DE, Pandey A, Lodish HF. Context-specific effects of fibulin-5 (DANCE/EVEC) on cell proliferation, motility, and invasion. Fibulin-5 is induced by transforming growth factor-beta and affects protein kinase cascades. J Biol Chem 2002;277(30):27367-77. (Pubitemid 34951757)
19. Hu B, Thirtamara-Rajamani KK, Sim H, Viapiano MS. Fibulin-3 is uniquely upregulated in malignant gliomas and promotes tumor cell motility and invasion. Mol Cancer Res 2009;7(11):1756-70.
20. Camaj P, Seeliger H, Ischenko I, Krebs S, Blum H, De Toni EN, et al. EFEMP1 binds the EGF receptor and activates MAPK and Akt pathways in pancreatic carcinoma cells. Biol Chem 2009;390(12):1293-302.
21. Hawinkels LJ, Kuiper P, Wiercinska E, Verspaget HW, Liu Z, Pardali E, et al. Matrix metalloproteinase-14 (MT1-MMP)-mediated endoglin shedding inhibits tumor angiogenesis. Cancer Res 2010;70(10):4141-50.
22. Miki T, Shamma A, Kitajima S, Takegami Y, Noda M, Nakashima Y, et al. The beta1- integrin-dependent function of RECK in physiologic and tumor angiogenesis. Mol Cancer Res 2010;8(5):665-76.
23. Tchaicha JH, Mobley AK, Hossain MG, Aldape KD, McCarty JH. A mosaic mouse model of astrocytoma identifies alphavbeta8 integrin as a negative regulator of tumor angiogenesis. Oncogene 2010;29(31):4460-72.
24. Purushothaman A, Uyama T, Kobayashi F, Yamada S, Sugahara K, Rapraeger AC, et al. Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis. Blood 2010;115(12):2449-57.
25. L'Heureux DZ, Rothman VL, Tuszynski GP. The interaction of angiocidin with tissue transglutaminase. Exp Mol Pathol 2010;88(1):15-25.
26. Abraham D, Zins K, Sioud M, Lucas T, Schäfer R, Stanley ER, et al. Stromal cell-derived CSF-1 blockade prolongs xenograft survival of CSF-1-negative neuroblastoma. Int J Cancer 2010;126(6):1339-52.
27. Chetty C, Lakka SS, Bhoopathi P, Rao JS. MMP-2 alters VEGF expression via alphaVbeta3 integrin-mediated PI3K/AKT signaling in A549 lung cancer cells. Int J Cancer 2009;127(5):1081-95.
28. Hawinkels LJ, Zuidwijk K, Verspaget HW, de Jonge-Muller ES, van Duijn W, Ferreira V, et al. VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis. Eur J Cancer 2008;44(13):1904-13.
29. Liu B, Faia L, Hu M, Nussenblatt RB. Pro-angiogenic effect of IFNgamma is dependent on the PI3K/mTOR/translational pathway in human retinal pigmented epithelial cells. Mol Vis 2010;16:184-93.
30. Tsutsui S, Matsuyama A, Yamamoto M, Takeuchi H, Oshiro Y, Ishida T, et al. The Akt expression correlates with the VEGF-A and -C expression as well as the microvessel and lymphatic vessel density in breast cancer. Oncol Rep 2010;23(3):621-30.